Exact Mass: 753.2819572000001
Exact Mass Matches: 753.2819572000001
Found 13 metabolites which its exact mass value is equals to given mass value 753.2819572000001,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Rifamycin O
Rifamycin O
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D012294 - Rifamycins
1alpha,2alpha,6beta-triacetoxy-9beta-benzoyloxy-15(2)-methylbutyroyloxy-4beta-hydroxy-8alpha-nicotynoyloxy-dihydro-beta-agarofuran
1alpha,2alpha,6beta-triacetoxy-9beta-benzoyloxy-15(2)-methylbutyroyloxy-4beta-hydroxy-8alpha-nicotynoyloxy-dihydro-beta-agarofuran
4-Fluoro-1,3-dihydro-2H-isoindole-2-carboxylic acid (2R,6S,12Z,13aS,14aR,16aS)-14a-[[(cyclopropylsulfonyl)amino]carbonyl]-6-[[(1,1-dimethylethoxy)carbonyl]amino]-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydro-5,16-dioxocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-2-yl ester sodium salt
4-Fluoro-1,3-dihydro-2H-isoindole-2-carboxylic acid (2R,6S,12Z,13aS,14aR,16aS)-14a-[[(cyclopropylsulfonyl)amino]carbonyl]-6-[[(1,1-dimethylethoxy)carbonyl]amino]-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydro-5,16-dioxocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-2-yl ester sodium salt
C35H45FN5O9S.Na (753.2819572000001)
[(1R,2R,3S,4S,5S,6E,22E,24Z,26S,30S)-2,4,5,26,30,32-hexahydroxy-3,5,7,13,18,22,26,31-octamethyl-14,21,29-trioxo-9,11,28-trioxa-20-azapentacyclo[25.2.2.18,12.115,19.016,33]tritriaconta-6,8(33),12,15(32),16,18,22,24-octaen-17-yl] acetate
[(1R,2R,3S,4S,5S,6E,22E,24Z,26S,30S)-2,4,5,26,30,32-hexahydroxy-3,5,7,13,18,22,26,31-octamethyl-14,21,29-trioxo-9,11,28-trioxa-20-azapentacyclo[25.2.2.18,12.115,19.016,33]tritriaconta-6,8(33),12,15(32),16,18,22,24-octaen-17-yl] acetate
1-[(3S,9R,10R)-9-[[(3,5-dimethyl-4-isoxazolyl)sulfonyl-methylamino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-[4-(trifluoromethyl)phenyl]urea
1-[(3S,9R,10R)-9-[[(3,5-dimethyl-4-isoxazolyl)sulfonyl-methylamino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-[4-(trifluoromethyl)phenyl]urea
1-[(3R,9S,10S)-9-[[(3,5-dimethyl-4-isoxazolyl)sulfonyl-methylamino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-[4-(trifluoromethyl)phenyl]urea
1-[(3R,9S,10S)-9-[[(3,5-dimethyl-4-isoxazolyl)sulfonyl-methylamino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-[4-(trifluoromethyl)phenyl]urea
rifamycin B(2-)
rifamycin B(2-)
A hydroxy monocarboxylic acid anion arising from deprotonation of the carboxy and 5-carboxy groups of rifamycin B; major species at pH 7.3.
(7's,9'e,11's,12'r,13's,14'r,15'r,16'r,17's,18's,19'e,21'z)-2',15',17',23'-tetrahydroxy-11'-methoxy-3',7',12',14',16',18',22'-heptamethyl-4,6',29'-trioxo-8',30'-dioxa-24'-azaspiro[1,3-dioxolane-2,27'-tetracyclo[23.3.1.1⁴,⁷.0⁵,²⁸]triacontan]-1',3',5'(28'),9',19',21',23',25'-octaen-13'-yl acetate
(7's,9'e,11's,12'r,13's,14'r,15'r,16'r,17's,18's,19'e,21'z)-2',15',17',23'-tetrahydroxy-11'-methoxy-3',7',12',14',16',18',22'-heptamethyl-4,6',29'-trioxo-8',30'-dioxa-24'-azaspiro[1,3-dioxolane-2,27'-tetracyclo[23.3.1.1⁴,⁷.0⁵,²⁸]triacontan]-1',3',5'(28'),9',19',21',23',25'-octaen-13'-yl acetate
(2s,8s,15s,18s,24s)-10,17,26-trihydroxy-24-[(4-hydroxyphenyl)methyl]-15-isopropyl-8-[2-(methylsulfanyl)ethyl]-13,29-dithia-6,9,16,22,25,30,31-heptaazapentacyclo[25.2.1.1¹¹,¹⁴.0²,⁶.0¹⁸,²²]hentriaconta-1(30),9,11,14(31),16,25,27-heptaene-7,23-dione
(2s,8s,15s,18s,24s)-10,17,26-trihydroxy-24-[(4-hydroxyphenyl)methyl]-15-isopropyl-8-[2-(methylsulfanyl)ethyl]-13,29-dithia-6,9,16,22,25,30,31-heptaazapentacyclo[25.2.1.1¹¹,¹⁴.0²,⁶.0¹⁸,²²]hentriaconta-1(30),9,11,14(31),16,25,27-heptaene-7,23-dione